Search Results - "BOVENZI, Veronica"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Valproate Induces Replication-independent Active DNA Demethylation by Detich, Nancy, Bovenzi, Veronica, Szyf, Moshe

    Published in The Journal of biological chemistry (25-07-2003)
    “…In this report, we demonstrate that valproic acid (VPA), a drug that has been used for decades in the treatment of epilepsy and as a mood stabilizer, triggers…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Antitumor activity of cell‐penetrant kinin B1 receptor antagonists in human triple‐negative breast cancer cells by Dubuc, Céléna, Savard, Martin, Bovenzi, Veronica, Lessard, Andrée, Côté, Jérôme, Neugebauer, Witold, Geha, Sameh, Chemtob, Sylvain, Gobeil, Fernand

    Published in Journal of cellular physiology (01-03-2019)
    “…High nuclear expression of G protein‐coupled receptors, including kinin B1 receptors (B1R), has been observed in several human cancers, but the clinical…”
    Get full text
    Journal Article
  5. 5
  6. 6

    DNA methylation and cancer by Momparler, Richard L., Bovenzi, Veronica

    Published in Journal of cellular physiology (01-05-2000)
    “…The methylation of DNA is an epigenetic modification that can play an important role in the control of gene expression in mammalian cells. The enzyme involved…”
    Get full text
    Journal Article
  7. 7

    Bradykinin protects against brain microvascular endothelial cell death induced by pathophysiological stimuli by Bovenzi, Veronica, Savard, Martin, Morin, Josée, Cuerrier, Charles M., Grandbois, Michel, Gobeil Jr, Fernand

    Published in Journal of cellular physiology (01-01-2010)
    “…The morphological and functional integrity of the microcirculation is compromised in many cardiovascular diseases such as hypertension, diabetes, stroke, and…”
    Get full text
    Journal Article
  8. 8

    Structure–activity relationships of novel peptide agonists of the human bradykinin B2 receptor by Bélanger, Simon, Bovenzi, Veronica, Côté, Jérome, Neugebauer, Witold, Amblard, Muriel, Martinez, Jean, Lammek, Bernard, Savard, Martin, Gobeil, Fernand

    Published in Peptides (New York, N.Y. : 1980) (01-04-2009)
    “…The nonapeptide bradykinin (BK) is involved in the genesis of inflammation, edema and in pain mediation. As such, much effort has gone into the development of…”
    Get full text
    Journal Article
  9. 9

    Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activation by Savard, Martin, Barbaz, David, Bélanger, Simon, Müller-Esterl, Werner, Bkaily, Ghassan, D'orléans-Juste, Pedro, Coté, Jérôme, Bovenzi, Veronica, Gobeil Jr, Fernand

    Published in Journal of cellular physiology (01-07-2008)
    “…Bradykinin (BK) represents a pro‐inflammatory mediator that partakes in many inflammatory diseases. The mechanism of action of BK is thought to be primarily…”
    Get full text
    Journal Article
  10. 10

    Methylated DNA-binding protein 2 antisense inhibitors suppress tumourigenesis of human cancer cell lines in vitro and in vivo by Campbell, Paul M., Bovenzi, Veronica, Szyf, Moshe

    Published in Carcinogenesis (New York) (01-04-2004)
    “…Methylated DNA-binding protein 2 (MBD2) has been proposed to function both as a silencer of methylated genes and as a DNA demethylase. Our previous data…”
    Get full text
    Journal Article
  11. 11

    Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor β and estrogen receptor α genes in breast carcinoma cells by BOVENZI, Veronica, MOMPARLER, Richard L

    Published in Cancer chemotherapy and pharmacology (01-07-2001)
    “…During tumorigenesis several cancer-related genes can be silenced by aberrant methylation. In many cases these silenced genes can be reactivated by exposure to…”
    Get full text
    Journal Article
  12. 12

    Selective tumor blood–brain barrier opening with the kinin B2 receptor agonist [Phe8 ψ (CH2 NH)Arg9 ]-BK in a F98 glioma rat model: An MRI study by Côté, Jérôme, Savard, Martin, Bovenzi, Veronica, Dubuc, Céléna, Tremblay, Luc, Tsanaclis, Ana Maria, Fortin, David, Lepage, Martin, Gobeil, Fernand

    Published in Neuropeptides (Edinburgh) (01-04-2010)
    “…Abstract Treatment of malignant glioma with chemotherapy is limited mostly because of delivery impediment related to the blood–brain barrier (BBB). One…”
    Get full text
    Journal Article Conference Proceeding
  13. 13

    Novel kinin B1 receptor agonists with improved pharmacological profiles by Côté, Jérôme, Savard, Martin, Bovenzi, Veronica, Bélanger, Simon, Morin, Josée, Neugebauer, Witold, Larouche, Annie, Dubuc, Céléna, Gobeil, Fernand

    Published in Peptides (New York, N.Y. : 1980) (01-04-2009)
    “…There is some evidence to suggest that inducible kinin B1 receptors (B1R) may play beneficial and protecting roles in cardiovascular-related pathologies such…”
    Get full text
    Journal Article
  14. 14

    Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe super(8)[psi](CH sub(2)NH)Arg super(9)]-BK in a F98 glioma rat model: An MRI study by Cote, Jerome, Savard, Martin, Bovenzi, Veronica, Dubuc, Celena, Tremblay, Luc, Tsanaclis, Ana Maria, tin, David, Lepage, Martin, Gobeil, Fernand

    Published in Neuropeptides (Edinburgh) (01-04-2010)
    “…Treatment of malignant glioma with chemotherapy is limited mostly because of delivery impediment related to the blood-brain barrier (BBB). One approach for…”
    Get full text
    Journal Article
  15. 15

    Antisense MBD2 gene therapy inhibits tumorigenesis by Slack, Andrew, Bovenzi, Veronica, Bigey, Pascal, Ivanov, M. A., Ramchandani, Shyam, Bhattacharya, Sanjoy, tenOever, Benjamin, Lamrihi, B., Scherman, Daniel, Szyf, Moshe

    Published in The journal of gene medicine (01-07-2002)
    “…Background Aberration in the pattern of DNA methylation is one of the hallmarks of cancer. We present data suggesting that dysregulation of MBD2, a recently…”
    Get full text
    Journal Article
  16. 16

    Preclinical evaluation of 5-aza-2'-deoxycytidine, an inhibitor of DNA methylation, for therapy of breast cancer by Bovenzi, Veronica

    “…Breast cancer is the second most common cause of cancer death among women in the United States. Chemotherapy and hormonal therapy have proven to be effective…”
    Get full text
    Dissertation
  17. 17

    DNA methylation of retinoic acid receptor beta in breast cancer and possible therapeutic role of 5-aza-2'-deoxycytidine by Bovenzi, V, Lê, N L, Côte, S, Sinnett, D, Momparler, L F, Momparler, R L

    Published in Anti-cancer drugs (01-06-1999)
    “…The retinoic acid receptor beta (RARbeta), a putative tumor suppressor gene, has been reported to be poorly expressed in breast cancer. In this report using…”
    Get more information
    Journal Article
  18. 18

    Quantitation of Inhibition of DNA Methylation of the Retinoic Acid Receptor β Gene by 5-Aza-2′-deoxycytidine in Tumor Cells Using a Single-Nucleotide Primer Extension Assay by Bovenzi, Veronica, Momparler, Richard L.

    Published in Analytical biochemistry (15-05-2000)
    “…The expression of several cancer-related genes has been reported to be silenced by DNA methylation of their promoter region. 5-Aza-2′-deoxycytidine…”
    Get full text
    Journal Article